CURRENT EVIDENCE-BASED MANAGEMENT Lifestyle First-Line Therapy Calorie deficit nutrition High-fiber anti-inflammatory diet Regular physical activity Sleep correction Stress reduction Pharmacological Options (When Indicated) GLP-1 receptor agonists (Semaglutide / Liraglutide) Dual GIP-GLP-1 agonist (Tirzepatide) SGLT-2 inhibitors in diabetic patients Metformin for insulin resistance & metabolic syndrome Evaluate Associated Conditions Always screen for: Hypertension Type 2 Diabetes Dyslipidemia Fatty liver disease Sleep apnea PCOS Cardiovascular disease Treat the inflammation not just the weight
GLP-1 Receptor Activity, Appetite, and Satiety GLP-1 receptor activation can increase glucose-dependent insulin release, reduce glucagon secretion, slow gastric emptying, and influence central appetite pathways [11]
Why Appearance Is Not Enough Clear, colourless material may still have experienced: Concentration loss
Entry into the abdomen is done with a see-through device, so each layer of the abdominal wall is identified as it's entered
This follows a strong growth trend as consumer trust and interest in telemedicine increases, with applications increasing by 47% from 2022 to 2023
The subcutaneous administration of any medication can cause temporary irritation of nerve endings in the skin and subcutaneous tissue